Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for AngioDynamics, Inc. (ANGO : NSDQ)
 
 • Company Description   
AngioDynamics Inc. designs, manufactures and sells a wide range of medical, surgical and diagnostic devices. The devices are generally used in minimally invasive, image-guided procedures. AngioDynamics product offerings fall within three Global Business Units, namely Oncology/Surgery, Endovascular Therapies and Vascular Access. Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products and Venous Insufficiency. The Thrombus Management portfolio includes the proprietary AngioVac venous drainage cannula and circuit as well as catheter directed thrombolytic devices. Vascular Access arm offers advanced imaging equipment to guide the placement of catheters that primarily deliver short-term drug therapies. IGVA procedures include the placement of Peripherally Inserted Central Catheters lines, implantable ports and central venous catheters. Oncology/Surgery division includes Microwave Ablation, Radiofrequency Ablation and NanoKnife product lines.

Number of Employees: 800

 
 • Price / Volume Information   
Yesterday's Closing Price: $19.25 Daily Weekly Monthly
20 Day Moving Average: 212,189 shares
Shares Outstanding: 38.72 (millions)
Market Capitalization: $745.30 (millions)
Beta: 0.88
52 Week High: $32.00
52 Week Low: $17.56
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -19.92% -9.82%
12 Week -12.94% -4.29%
Year To Date -30.20% -14.81%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
14 PLAZA DRIVE
-
LATHAM,NY 12110
USA
ph: 518-795-1400
fax: 518-795-1401
mpolyviou@evcgroup.com http://www.angiodynamics.com
 
 • General Corporate Information   
Officers
James C. Clemmer - President and Chief Executive Officer
Howard W. Donnelly - Chairman and Director
Stephen A. Trowbridge - Executive Vice President and Chief Financial Offic
Wesley E. Johnson, Jr. - Director
Dennis S. Meteny - Director

Peer Information
AngioDynamics, Inc. (ABMD)
AngioDynamics, Inc. (DMDS)
AngioDynamics, Inc. (CPWY.)
AngioDynamics, Inc. (EQUR)
AngioDynamics, Inc. (ECIA)
AngioDynamics, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 03475V101
SIC: 3841
Fiscal Year
Fiscal Year End: May
Last Reported Quarter: 02/01/22
Next Expected EPS Date: 07/12/22
Share - Related Items
Shares Outstanding: 38.72
Most Recent Split Date: (:1)
Beta: 0.88
Market Capitalization: $745.30 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.01 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.01 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/12/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.73
Price/Cash Flow: 26.44
Price / Sales: 2.44
EPS Growth
vs. Year Ago Period: 50.00%
vs. Previous Quarter: 250.00%
Sales Growth
vs. Year Ago Period: 3.92%
vs. Previous Quarter: -5.51%
ROE
02/28/22 - -0.12
11/30/21 - -0.24
08/31/21 - 0.08
ROA
02/28/22 - -0.09
11/30/21 - -0.19
08/31/21 - 0.06
Current Ratio
02/28/22 - 2.59
11/30/21 - 2.43
08/31/21 - 2.52
Quick Ratio
02/28/22 - 1.61
11/30/21 - 1.54
08/31/21 - 1.57
Operating Margin
02/28/22 - -0.16
11/30/21 - -0.35
08/31/21 - 0.12
Net Margin
02/28/22 - -12.99
11/30/21 - -12.64
08/31/21 - -11.50
Pre-Tax Margin
02/28/22 - -14.76
11/30/21 - -14.36
08/31/21 - -13.38
Book Value
02/28/22 - 11.10
11/30/21 - 11.19
08/31/21 - 11.28
Inventory Turnover
02/28/22 - 2.98
11/30/21 - 2.91
08/31/21 - 2.78
Debt-to-Equity
02/28/22 - 0.06
11/30/21 - 0.06
08/31/21 - 0.06
Debt-to-Capital
02/28/22 - 5.50
11/30/21 - 5.47
08/31/21 - 5.42
 

Powered by Zacks Investment Research ©